MP17-06 THYROID HORMONES AND BENIGN PROSTATIC HYPERPLASIA

Zinc and Androgen Hormones in Benign Prostatic Hyperplasia

Benign prostatic hypertrophy is one of the most common causes of urological addressability because of the symptoms that rapidly and visibly decrease patients’ quality of life. Objectives: The authors analyzed zinc and androgen hormones status in patients with prostate disorders and Corresponding author: Dr. CSPI Ilinca Nicolae 030303, Sos. Mihai Bravu, no. 281, sector III, Bucharest, Romania e-...

Benign prostatic hyperplasia.

This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic rec...

Benign Prostatic Hyperplasia

Urinary obstruction as a result of benign prostatic disease has probably been recognized to some degree since the earl iest days of medicine. This association was probably f irst formalized by Riolan in the seventeenth century. In the mideighteenth century, Morgagni (248) provided one of the earl iest descriptions of BPH and enumerated many of the potential medical problems attendant to its dev...

Benign Prostatic Hyperplasia (bph)

Comprehensive studies show that the holmium laser is ideal for treating BPH. Holmium laser treatments have been the most rigorously investigated BPH techniques. Over 90 articles have been published from 8 randomized clinical trials and over 30 case studies and comparative series. The American, European, British and Australasian urology associations recommend holmium laser for BPH treatment. Hol...

Benign prostatic hyperplasia.